rummageo chemical perturbations (Gene Set Library)

Project: Library of Integrated Network-based Cellular Signatures

Asset: Asset Page

Gene coverage: 31,387

Gene sets: 5,287

Download: https://cfde-drc.s3.amazonaws.com/LINCS/XMT/2024-12-19/rummageo_chemical_perturbations.gmt

Description: A gene set library provided by LINCS

Analyze

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with rummageo chemical perturbations.

Gene sets

Label	Description
GSE179112 GSE179113 hydroxyl Hutt45 4 v 3 human dn Gene Set (Entity type)	A gene set from rummageo chemical perturbations provided by LINCS
GSE89154 proscillaridin 1 v 3 human dn Gene Set (Entity type)	A gene set from rummageo chemical perturbations provided by LINCS
GSE171837 bortezomib 0 v 1 human up Gene Set (Entity type)	A gene set from rummageo chemical perturbations provided by LINCS
GSE120612 etoposide leukocyte 7 v 2 human dn Gene Set (Entity type)	A gene set from rummageo chemical perturbations provided by LINCS
GSE118548 trametinib T84 1 v 2 human up Gene Set (Entity type)	A gene set from rummageo chemical perturbations provided by LINCS
GSE163297 doxorubicin 0 v 2 human dn Gene Set (Entity type)	A gene set from rummageo chemical perturbations provided by LINCS
GSE233647 docetaxel UFERSA-PC3 DU145 4 v 0 human dn Gene Set (Entity type)	A gene set from rummageo chemical perturbations provided by LINCS
GSE115542 digoxin 5 v 1 human dn Gene Set (Entity type)	A gene set from rummageo chemical perturbations provided by LINCS
GSE182680 GSE182683 dexamethasone 10 v 3 human dn Gene Set (Entity type)	A gene set from rummageo chemical perturbations provided by LINCS
GSE151412 sorafenib 2 v 1 human up Gene Set (Entity type)	A gene set from rummageo chemical perturbations provided by LINCS

GSE179112 GSE179113 hydroxyl Hutt45 4 v 3 human dn
Gene Set (Entity type)
A gene set from rummageo chemical perturbations provided by LINCS

GSE89154 proscillaridin 1 v 3 human dn
Gene Set (Entity type)
A gene set from rummageo chemical perturbations provided by LINCS

GSE171837 bortezomib 0 v 1 human up
Gene Set (Entity type)
A gene set from rummageo chemical perturbations provided by LINCS

GSE120612 etoposide leukocyte 7 v 2 human dn
Gene Set (Entity type)
A gene set from rummageo chemical perturbations provided by LINCS

GSE118548 trametinib T84 1 v 2 human up
Gene Set (Entity type)
A gene set from rummageo chemical perturbations provided by LINCS

GSE163297 doxorubicin 0 v 2 human dn
Gene Set (Entity type)
A gene set from rummageo chemical perturbations provided by LINCS

GSE233647 docetaxel UFERSA-PC3 DU145 4 v 0 human dn
Gene Set (Entity type)
A gene set from rummageo chemical perturbations provided by LINCS

GSE115542 digoxin 5 v 1 human dn
Gene Set (Entity type)
A gene set from rummageo chemical perturbations provided by LINCS

GSE182680 GSE182683 dexamethasone 10 v 3 human dn
Gene Set (Entity type)
A gene set from rummageo chemical perturbations provided by LINCS

GSE151412 sorafenib 2 v 1 human up
Gene Set (Entity type)
A gene set from rummageo chemical perturbations provided by LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.